This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

3 Health Care Buys for 2012


WellPoint (WLP) is also a popular pick for 2012 with 18 of the 24 analysts covering the stock at either strong buy (9) or buy (9), and the median 12-month price target sitting at $87 vs. Tuesday's close at $67.93.

Caroll of Stifel Nicolaus also likes WellPoint, which he sees as a pure play on the insurance space. He's expecting the company to generate earnings of close to $8 per share next year. The current average analysts' estimate is at $7.75, giving the stock a relatively cheap forward price-to-earnings multiple of less than 9X at present levels.

Though Carroll recommends WellPoint, he noted that investors should be aware the company is more exposed to health care reform than some of its peers. His price target for the shares is $90.

The stock has gained 19% in 2011, and the Indianapolis-based health care benefits provider is tentatively expected to report its fiscal fourth-quarter results on Jan. 25 with Wall Street expecting earnings of $1.11 a share in the December quarter on revenue of $15.38 billion.

TheStreet Ratings gives WellPoint a B grade with a buy rating and a $64.50 price target.

>>To see these stocks in action, visit the 3 Health Care Buys for 2012 portfolio on Stockpickr.

-- Written by Alexandra Zendrian in New York.

>To contact the writer of this article, click here: Alexandra Zendrian

>To submit a news tip, send an email to:

>To follow the writer on Twitter, go to Alexandra Zendrian.
4 of 4

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free
WLP $136.01 1.43%
CVS $95.86 0.00%
UNH $111.82 0.00%
AAPL $93.99 0.00%
FB $102.01 0.00%


Chart of I:DJI
DOW 15,973.84 +313.66 2.00%
S&P 500 1,864.78 +35.70 1.95%
NASDAQ 4,337.5120 +70.6750 1.66%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs